Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: A systematic review and meta-analysis
Medicine (United States), ISSN: 1536-5964, Vol: 95, Issue: 3, Page: e2544
2016
- 60Citations
- 70Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations60
- Citation Indexes60
- 60
- CrossRef33
- Captures70
- Readers70
- 55
- 15
- Mentions2
- References2
- Wikipedia2
Article Description
Inflammation is increasingly reported to be associated with the prognosis of patients with cancers. And the prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with prostate cancer (PCa) remains inconsistent. Therefore, we conducted this systematic review and meta-analysis to obtain a more reliable assessment of prognostic significance of NLR in PCa. A comprehensive literature research regarding the association of NLR and prognosis of PCa was performed through PubMed, Embase, Cochrane Central, and Web of Science. The hazard ratios (HRs) and its 95% confidence intervals (CIs) for overall survival (OS), progressionfree survival, or recurrence-free survival were extracted and pooled using fix-effects model or random-effects model. A total of 14 studies that met our criterion were included in this meta-analysis. Our pooled results demonstrated that elevated NLR was not significantly associated with the poor OS (HR=1.45; 95% CI 0.77- 2.71; P=0.248) or recurrence-free survival (HR=1.34; 95% CI 0.89-2.02; P=0.155) of patients with localized PCa. Although elevated NLR predicted poorer OS (HR=1.57; 95% CI 1.41-1.74; P<0.001) and progression-free survival (HR=1.97; 95% CI 1.28-3.04; P=0.002) of patients with metastatic castration resistant prostate cancer (mCRPC). Elevated NLR is a strong indicator of poorer prognosis of patients with mCRPC, whereas the NLR is not significantly associated with prognosis of patients with localized PCa. Therefore, NLR could be used in patients with mCRPC for risk stratification and decision making of individual treatment.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84971379536&origin=inward; http://dx.doi.org/10.1097/md.0000000000002544; http://www.ncbi.nlm.nih.gov/pubmed/26817900; https://journals.lww.com/00005792-201601190-00041; http://Insights.ovid.com/crossref?an=00005792-201601190-00041; https://dx.doi.org/10.1097/md.0000000000002544; https://journals.lww.com/md-journal/Fulltext/2016/01190/Prognostic_Role_of_Neutrophil_to_Lymphocyte_Ratio.41.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know